N@N

ICFI, VICL, IRC, ARIA, GLCH, CETV Expected To Be Down Before Next Earnings Releases

October 26, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. ICF International Inc (NASDAQ:ICFI), Vical Inc (NASDAQ:VICL), Inland Real Estate Corp (NYSE:IRC), ARIAD Pharmaceuticals Inc (NASDAQ:ARIA), Gleacher And Co Inc (NASDAQ:GLCH), Central European Media Enterprises Ltd (NASDAQ:CETV) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Friday:

  Symbol  Company                          # of Reports         Quarter  Release Date
  ICFI    ICF International Inc            6 Quarter            Q3       11/02/2012
  VICL    Vical Inc                        November Earnings    Q3       11/01/2012
  IRC     Inland Real Estate Corp          6 Quarter            Q3       11/01/2012
  ARIA    ARIAD Pharmaceuticals Inc        6 Quarter            Q3       11/01/2012
  GLCH    Gleacher And Co Inc              6 Quarter            Q3       11/01/2012
  CETV    Central European Media Enterprises Ltd  12 Quarter           Q3       10/31/2012

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

ICF International Inc (NASDAQ:ICFI) - ICF International, Inc. provides management, technology, and policy consulting and implementation services to government, commercial, and international clients worldwide. Its advisory services include needs and market assessments, policy analysis, strategy and concept development, organizational assessment and strategy, enterprise architecture, and program design; and implementation services comprise information technology solutions, project and program management, project delivery, strategic communications, and training. The company also provides evaluation and improvement services consisting of program evaluation, continuous improvement initiatives, performance management, benchmarking, and return-on-investment analyses. It serves energy, environment, and infrastructure; health, human services, and social programs; and homeland security and defense markets. ICF International was formerly known as ICF Consulting Group Holdings, LLC and changed its name to ICF International, Inc. in 2006. The company was founded in 1969 and is headquartered in Fairfax, Virginia..

Vical Inc (NASDAQ:VICL) - Vical Incorporated engages in the research and development of biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its products include Allovectin-7 immunotherapeutic, a Phase III clinical trial product to treat metastatic melanoma; TransVax, a Phase II clinical trial product to prevent viral reactivation and disease after transplant; Prophylactic vaccine for H5N1 pandemic influenza virus, which completed Phase I clinical trial to protect against infection, disease, and/or viral shedding; Prophylactic vaccine for H1N1 pandemic influenza virus, which is under preclinical trial to protect against infection, disease, and/or viral shedding; CyMVectin prophylactic vaccine for cytomegalovirus, which is under preclinical trial to prevent infection before and during pregnancy; and Therapeutic vaccine for herpes simplex type 2 virus, which is under research to prevent recurring flare-ups. The company, through corporate collaborations, develops Collategene angiogenic therapy encoding Hepatocyte Growth Factor, Temusi angiogenic therapy encoding Fibroblast Growth Factor 1, and Angiogenic therapy encoding Hepatocyte Growth Factor to induce local growth of blood vessels to restore blood flow to limbs and heart affected by ischemia; Therapeutic vaccine encoding human telomerase reverse transcriptase to treat non-small cell lung, prostate cancer, melanoma, or carcinomas of the upper GI tract, colon, kidney, or bladder; Prophylactic and/or therapeutic hepatitis C vaccine to protect farm-raised salmon from infection; and ONCEPT therapeutic cancer vaccine encoding human tyrosinase for the treatment to increase survival time of dogs with oral melanoma. Vical Incorporated, through government collaboration, develops Prophylactic and/or therapeutic HIV vaccine to prevent/treat infection or disease. The company was founded in 1987 and is based in San Diego, California..

Inland Real Estate Corp (NYSE:IRC) - Inland Real Estate Corporation, a real estate investment trust (REIT), engages in the ownership, operation, and development of shopping centers and single-tenant retail properties in the Midwest region of the United States. As of December 31, 2007, the company owned interests in 152 investment properties, comprising 70 neighborhood retail centers totaling approximately 4,397,000 gross leasable square feet; 20 community centers totaling approximately 3,007,000 gross leasable square feet; 28 power centers totaling approximately 4,622,000 gross leasable square feet; 1 lifestyle center totaling approximately 562,000 gross leasable square feet; and 33 single-user properties totaling approximately 2,139,000 gross leasable square feet. Inland Real Estate Corporation has elected to be taxed as a REIT under the Internal Revenue Code and would not be subject to federal income tax to the extent it distributes at least 90% of its REIT taxable income to stockholders. The company was formed in 1994 and is based in Oak Brook, Illinois..

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA) - ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer in the United States, Europe, and Japan. The companys lead cancer product candidate, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including sarcomas, breast cancer, prostate cancer, non-small cell lung cancer, and endometrial cancer. It is also developing AP24534, an investigational pan BCR-ABL inhibitor, which is in Phase I clinical trial for the treatment of chronic myeloid leukemia, acute myeloid leukemia, and other hematologic cancers. In addition, the company is developing AP26113, an investigational anaplastic lymphoma kinase inhibitor, which is in the preclinical stage for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. Further, it has license to technology and patents related to certain NF-κB cell-signaling activity, which may be useful in treating certain diseases. Additionally, the company licenses ARGENT technology, a portfolio of cell-signaling regulation technologies to control intracellular processes with small molecules, which is useful in the development of therapeutic vaccines and gene and cell therapy products, as well as provide various tools for use in cell biology, functional genomics, and drug discovery research. ARIAD Pharmaceuticals, Inc. has a collaboration agreement with Merck & Co., Inc. for the joint development and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to prevent restenosis or reblockage of injured vessels following interventions. The company was founded in 1991 and is based in Cambridge, Massachusetts..

Gleacher And Co Inc (NASDAQ:GLCH) - Gleacher & Company, Inc., an independent investment bank, provides corporations and institutional investors with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization and strategic alternative analysis services, as well as securities brokerage for institutional customers primarily in the United States. It operates in five segments: Broadpoint Descap, Debt Capital Markets, Investment Banking, Equities, and Other. The Broadpoint Descap segment offers sales and trading services on a range of mortgage and asset-backed securities; the U.S. Treasury and government agency securities; and structured products, such as collateralized loan obligations and collateralized debt obligations, whole loans, swaps, and other securities. This segment also provides execution services for institutional investor customer trades. The Debt Capital Markets segment offers sales and trading on corporate debt securities, including bank debt and loans, investment grade and high-yield debt, convertibles, distressed debt, preferred stock, and reorganization equities. The Investment Banking segment provides a range of financial advisory services in regards to mergers and acquisitions, restructurings, and corporate finance-related matters. This segment also raises capital for corporate clients through underwritings and private placements of debt and equity securities. The Equities segment provides sales, trading, and research on equity securities and offers services for corporate repurchase activities. The Other segment provides early-stage growth capital to companies. The company was formerly known as Broadpoint Gleacher Securities Group, Inc. and changed its name to Gleacher & Company, Inc. in May 2010. Gleacher & Company was founded in 1952 and is headquartered in New York, New York..

Central European Media Enterprises Ltd (NASDAQ:CETV) - Central European Media Enterprises Ltd. (CME) operates as a vertically integrated media company operating broadcast, content, and new media businesses in central and eastern European countries. CMEs television stations in Bulgaria comprise bTV, bTV Cinema, bTV Comedy, bTV Action, and Ring.bg; in Croatia include Nova TV, Doma, and Nova World; in the Czech Republic consist of TV Nova, Nova Cinema, Nova Sport, and MTV Czech; in Romania comprise PRO TV, PRO TV International, Acasa, PRO Cinema, PRO TV Chisinau, Sport.ro, and MTV Romania; in the Slovak Republic include TV Markza and Doma; and in Slovenia consist of POP TV, Kanal A, and POP Brio. The company was founded in 1994 and is based in Hamilton, Bermuda..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources

---